In consultation: Guidance and quality standards
Showing 1 to 6 of 6
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Suspected sepsis: recognition, diagnosis and early management | Draft guidance consultation | NICE guideline | |
| Chronic heart failure in adults: diagnosis and management | Draft guidance consultation | NICE guideline | |
| Obecabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia [ID6347] | Draft guidance | Technology appraisal guidance | |
| Belantamab mafodotin with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments [ID6212] | Draft guidance | Technology appraisal guidance | |
| Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer [ID6177] | Draft guidance | Technology appraisal guidance | |
| Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable ID3981 | Draft guidance | Technology appraisal guidance |